Anzeige
Mehr »
Samstag, 26.07.2025 - Börsentäglich über 12.000 News
Richtig investiert verwandelt der Goldpreis jeden Euro in glänzendes Vermögen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18.07.Astellas and KISED link to support Korean pharma startups
18.07.ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing
18.07.FDA approves GSK's prefilled syringe presentation of Shingrix
18.07.Can rare disease research in the US thrive under the new administration?
17.07.Ten years of Rare Pediatric Disease Designation: impact on drug approvals
17.07.Sarepta Therapeutics to cut 500 jobs amid restructuring
17.07.Thermo Fisher acquires Sanofi's steriles manufacturing site in US
16.07.PEPFAR funding protection offers "hope" for people living with HIV
16.07.UK government targets manufacturing as it eyes £41bn life science sector growth
16.07.GSK's Blenrep US comeback hindered by eye safety concerns
16.07.Why global 3PL providers are essential to easing supply chain challenges
16.07.Navamedic completes dne pharma acquisition
16.07.Acumen and JCR partner on brain delivery therapy for Alzheimer's
15.07.Sino Biopharma spends $951m to acquire China-based LaNova Medicines
15.07.Otsuka to acquire Cantargia's CAN10 for autoimmune diseases
15.07.Vertex and NHS England agree reimbursement for Alyftrek
15.07.LEO Pharma secures rights to Boehringer's Spevigo for $105m
15.07.Health Canada extends Evkeeza approval for children with HoFH
14.07.WHO endorses Gilead's Yeztugo for HIV prevention
14.07.Scaling smart: how small pharma companies can build resilient supply chains
14.07.Illimis secures funding for GAIA-based Alzheimer's therapeutics
14.07.GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients
14.07.Ultragenyx receives complete response letter for UX111 BLA
14.07.FDA to review MSD's doravirine/islatravir NDA for HIV-1
11.07.FDA issues more than 200 CRLs for transparency